Beyond BMI: An opinion on the clinical value of AI-powered CT body composition analysis
Biomolecules and Biomedicine · 07.07.2025 · 25 (12) · 2586-2593
DOI: 10.17305/bb.2025.12774 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 07.07.2025. Verfasst von Matej Pekar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Complex Cardiovascular Center, Hospital AGEL Trinec-Podlesi, Trinec, Czech Republic; Physiology, Faculty of Medicine, Masaryk University, Brno, Czech…. Hauptthemen laut MEDLINE: Tomography, X-Ray Computed, Body Composition, Body Mass Index, Artificial Intelligence. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Body Mass Index (BMI) has long been used as a standard measure for assessing population-level health risks, but its clinical adequacy has increasingly been called into question. This opinion paper challenges the clinical adequacy of BMI and presents AI-enhanced CT body composition analysis as a superior alternative for individualized risk assessment. While BMI serves population-level screening, its inability to differentiate between tissue types leads to critical misclassifications, particularly for sarcopenic obesity. AI-powered analysis of CT imaging at the L3 vertebra level provides precise quantification of skeletal muscle index, visceral, and subcutaneous adipose tissues -metrics that consistently outperform BMI in predicting outcomes across oncology, cardiology, and critical care. Recent technological advances have transformed this approach: the "opportunistic" use of existing clinical CT scans eliminates radiation concerns, while AI automation has reduced analysis time from 15-20 minutes to mere seconds. These innovations effectively address previous implementation barriers and enable practical clinical application with minimal resource demands, creating opportunities for targeted interventions and personalized care pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Complex Cardiovascular Center, Hospital AGEL Trinec-Podlesi, Trinec, Czech Republic; Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- Complex Cardiovascular Center, Hospital AGEL Trinec-Podlesi, Trinec, Czech Republic.
- Complex Cardiovascular Center, Hospital AGEL Trinec-Podlesi, Trinec, Czech Republic; Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic.
- Complex Cardiovascular Center, Hospital AGEL Trinec-Podlesi, Trinec, Czech Republic; Cardiac Surgery, Faculty of Medicine, Palacky University, Olomouc, Czech Republic.
Zitieren
APA
Pekar, M., Kantor, M., Balusik, J., Hecko, J., & Branny, P. (2025). Beyond BMI: An opinion on the clinical value of AI-powered CT body composition analysis. Biomolecules and Biomedicine, 25(12), 2586-2593. https://doi.org/10.17305/bb.2025.12774
Vancouver
Pekar M, Kantor M, Balusik J, Hecko J, Branny P. Beyond BMI: An opinion on the clinical value of AI-powered CT body composition analysis. Biomolecules and Biomedicine. 2025;25(12):2586-2593. doi:10.17305/bb.2025.12774
BibTeX
@article{Pekar2025,
author = {Pekar, Matej and Kantor, Marek and Balusik, Jakub and Hecko, Jan and Branny, Piotr},
title = {Beyond BMI: An opinion on the clinical value of AI-powered CT body composition analysis},
journal = {Biomolecules and Biomedicine},
year = {2025},
volume = {25},
number = {12},
pages = {2586--2593},
doi = {10.17305/bb.2025.12774}
}
EUVIMED